Recombinant Anti-Dabigatran etexilate Antibody (V3S-0723-FY24) (CAT#: V3S-0723-FY24)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description aDabi-Fab2a is derived from hybridoma cell line. aDabi-Fab2a recognizes Dabigatran etexilate. Dabigatran reversibly binds to the active site of the thrombin molecule, preventing thrombin-mediated activation of coagulation factors.
Clonality Monoclonal
Host Species Mouse
Target Species Non-species dependent
Immunogen Dabigatran-derived hapten
Isotype IgG

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein G purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; Neut; FuncS

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target Dabigatran etexilate
Alternative Name Dabigatran etexilate
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry